Crystal structure of the kinase domain of human vascular endothelial growth factor receptor 2: A key enzyme in angiogenesis

Structure

Volumn 7, Issue 3, 1999, Pages 319-330

  McTigue, Michele A ^a   Wickersham, John A ^a   Pinko, Chris ^a   Showalter, Richard E ^a   Parast V, Camran ^a   Tempczyk Russell, Anna ^a   Gehring, Michael R ^a   Mroczkowski, Barbara ^a   Chen Chen, Kan ^a   Villafranca, J Ernest ^a   Appelt, Krzysztof ^a  

^a AGOURON PHARMACEUTICALS INC   (United States)

Author keywords

Anglogenesis; Kinase insert domain; Signal transduction; Tyrosine kinase; X ray structure

Indexed keywords

PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

AMINO ACID SEQUENCE; ANGIOGENESIS; ARTICLE; CRYSTAL STRUCTURE; DRUG DESIGN; ENZYME MECHANISM; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; SIGNAL TRANSDUCTION; X RAY CRYSTALLOGRAPHY;

EID: 0033103867     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-2126(99)80042-2     Document Type: Article

References (53)

1. Folkman, J. & Shing, Y. (1992). Angiogenesis. J. Biol. Chem. 267, 10931-10934.
2. Risau, W. (1995). Differentiation of endothelium. FASEB J. 9, 926-933.
3. Pepper, M.S. (1996). Positive and negative regulation of angiogenesis: From cell biology to the clinic. Vasc. Med. 1, 259-266.
4. Kuiper, R.A.J., Schellens, J.H.M., Blijham, G.H., Beijnen, J.H. & Voest, E.E. (1998). Clinical research on antiangiogenic therapy. Pharmacol. Res. 37, 1-16.
5. Kumar, R. & Fidler, I.J. (1998). Angiogenic molecules and cancer metastasis. In Vivo 18, 27-34.
6. Szekanecz, Z., Szegedi, G. & Koch, A.E. (1998). Angiogenesis in rheumatoid arthritis: Pathogenic and clinical significance. J. Investig. Med. 46, 27-41.
7. Tolentino, M.J. & Adamis, A.P. (1988). Angiogenic factors in the development of diabetic iris neovascularization and retinopathy. Int. Ophthalmol. Clin. 38, 77-94.
8. Dvorak, H.F., Brown, L.F., Detmar, M. & Dvorak, A.M. (1995). Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146, 1029-1039.
9. Thomas, K.A. (1996). Vascular endothelial growth factor, a potent and selective angiogenic agent. Cell 271, 603-606.
10. Ferrara, N. & Davis-Smyth, T. (1997). The biology of vascular endothelial growth factor. Endocrine Rev. 18, 4-25.
11. Borgström, P., Hillan, K.J., Sriranarao, P. & Ferrara, N. (1996). Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibodies. Novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res. 56, 4032-4039.
12. Adamis, A.P., & Miller, J.W., et al., (1996). Inhibition of VEGF prevents retinal ischemia-associated iris neovascularization in a primate. Arch. Ophthalmol. 114, 66-71.
13. Jeltsch, M., & Alitalo, K., et al., (1997). Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276, 1423-1425.
14. Waltenberger, J., Claesson-Welsh, L., Siegbahn, A., Shibuya, M. & Heldin, C.-H. (1994). Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J. Biol. Chem. 269, 26988-26995.
15. Seetharam, L., Gotoh, N., Maru, Y., Neufeld, G., Yamaguchi, S. & Shibuya. M. (1995). A unique signal transduction pathway for the FLT tyrosine kinase, a receptor for vascular endothelial growth factor. Oncogene 10, 135-147.
16. Shalaby, F., Rossant., J., Gertsenstein, M., Wu, X.-F., Breitman, M.L. & Schuh, A.C. (1995). Failure of blood island formation and vasculogenesis in Flk-1 deficient mice. Nature 376, 576-579.
17. van der Greer, P., Hunter, T. & Lindberg, R.A. (1994). Receptor protein-tyrosine kinases and their signal transduction pathways. Annu. Rev. Cell Biol. 10, 251-337.
18. Taylor, G.R., Reedijk, M., Rothwell, V., Rohrschneider, L. & Pawson, T. (1989). The unique insert of cellular and viral fms protein tyrosine kinase domains is dispensable for enzymatic and transforming activities. EMBO J. 8, 2029-2037.
19. Heidaran, & Aaronson, S.A., et al., (1991 ). Deletion or substitution within the a platelet-derived growth factor receptor kinase insert domain: Effects on functional coupling with intracellular signalling pathways. Mol. Cell. Biol. 11, 134-142.
20. Yu, J.C., & Aaronson, S. A., et al., (1991) Tyrosine mutations within the a platelet-derived growth factor receptor kinase insert domain abrogate receptor-associated phosphatidylinositol-3 kinase activity without affecting mitogenic or chemotactic signal transduction. Mol. Cell. Biol. 11, 3780-3785.
21. Kazlauskas, A. & Cooper, J.A. (1989). Autophosphorylation of the PDGF receptor in the kinase insert region regulates interactions with cell proteins. Cell 58, 1121-1133.
22. Lev, S., Givol, D. & Yarden, Y. (1992). Interkinase domain of kit contains the binding site for phosphatidylinositol 3' kinase. Proc. Natl Acad. Sci. USA 89, 678-682.
23. Reedijk, M., & Pawson, T., et al., (1992) Tyr721 regulates specific binding of the CSF-1 receptor kinase insert to Pl 3′-kinase SH2 domains: A model for sh2-mediated receptor-target interactions. EMBO J. 11, 1365-1372.
24. Bazenet, C.E., Gelderloos, J.A. & Kazlauskas, A. (1996). Phosphorylation of tyrosine 720 in the platelet-derived growth factor a receptor is required for binding of Grb2 and SHP-2 but not for activation of Ras or cell proliferation. Mol. Cell. Biol. 16, 6926-6936.
25. Dougher-Vermazen, M., Hulmes, J.D., Bödhlen, P. & Terman, B.I. (1994). Biologicalical activity and phosphorylation sites of the bacterially expressed cytosolic domain of the KDR VEGF-receptor. Biochem. Biophys. Res. Commun. 205, 728-738.
26. Knighton, D.R., & Sowadski, J.M., et al., (1991). Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science 253, 407-413.
27. Johnson, L.N., Noble, M.E.M. & Owen, D.J. (1996). Active and inactive protein kinases: Structural basis for regulation. Cell 85, 149-158.
28. Hubbard, S.R., Wei, L., Ellis, L. & Hendrickson, W.A. (1994). Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature 372, 746-754
29. Hubbard, S.R. (1997). Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog. Embo J. 16, 5572-5581.
30. Mohammadi, M., Schlessinger, J. & Hubbard, S.R. (1996). Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism. Cell 86, 577-87.
31. Mohammadi, M., & Schlessinger, J., et al., (1997). Structures of the tyrosine kinase domain of the fibroblast growth factor receptor in complex with inhibitors. Science 276, 955-960.
32. Parast, C.V., Mroczkowski, B., Pinko, C., Misialek, S., Khambatta, G. & Appelt, K. (1998). Characterization and kinetic mechanism of catalytic domain of human vascular endothelial growth factor receptor-2 tyrosine kinase (VEGFR2 TK), a key enzyme in angiogenesis. Biochemistry 37, 16788-16801.
33. Cox, S., Radzio-Andzelm, E. & Taylor, S.S. (1994). Domain movements in protein kinases. Curr. Opin. Struct. Biol. 4, 893-901.
34. Yamaguchi, H. & Hendrickson., W.A. (1996). Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation. Nature 384, 484-489.
35. Zheng, J., & Sowadski, J.M., et al., (1993). Crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MgATP and a peptide inhibitor. Biochemistry 32, 2154-2161.
36. Severinsson, L., Ek, B., Mellström, K., Claesson-Welsh, L. & Heldin, C.-H. (1990). Deletion of the kinase insert sequence of the platelet-derived growth factor β-receptor affects receptor kinase activity and signal transduction. Mol. Cell. Biol. 10, 801-809.
37. Shibuya, M., & Sato, M., et al., (1990) Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene 5, 519-524.
38. Gronwald, R.G., & Murray, M.J., et al., (1988). Cloning and expression of a cDNA coding for the human platelet-derived growth factor receptor: Evidence for more than one receptor class. Proc. Natl Acad. Sci. USA 85, 3435-3439.
39. Matsui, T., & Aaronson, S., et al., (1989). Isolation of a novel receptor cdna establishes the existence of two PDGF receptor genes. Science 243, 800-804.
40. Yarden, Y., &, Ulrich, A., et al., (1987). EMBO J. 6, 3341-3351.
41. Kazlauskas, A. & Cooper, J.A. (1989). Autophosphorylation of the PDGF receptor in the kinase insert region regulates interactions with cell proteins. Cell 58, 1121-1133.
42. Terman, B.I., & Bohlen, P., et al., (1992). Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys. Res. Commun. 187, 1579-1586.
43. Mullis, K., Faloona, F., Scharf, S., Saiki, R., Horn, G. & Erlich, H. (1992). Specific enzymatic amplification of DNA in vitro: The polymerase chain reaction. (1986). Biotechnology 24, 17-27.
44. Wei, L., Hubbard, S.R., Hendrickson, W.A. & Ellis, L. (1995). Expression, characterization, and crystallization of the catalytic core of the human insulin receptor protein-tyrosine kinase domain. J. Biol. Chem. 270, 8122-8130.
45. Kunkel, T.A. (1985). Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl Acad. Sci. USA, 82, 488-492.
46. Schoner, B.E., Belagaje, R.M. & Schoner, R.G. (1986). Translation of a synthetic two-cistron mRNA in Escherichia coli. Proc. Natl Acad. Sci. USA, 83, 8506-8510.
47. Kan, C., Gehring, M.R., Nodes, B.R., Janson C.A., Almassy, R.J. & Hostomska, Z. (1992). Heterologous expression and purification of active human phosphoribosylglycinamide formyltransferase as a single domain. J. Protein Chem. 11, 467-73.
48. Otwinowski, Z. (1993). Oscillation data reduction program. In Proceedings of the CCP4 Study Weekend: Data Collection and Processing. (Sawyer L., Isaacs N. & Bailey, S., eds), pp. 56-62, SERC Daresbury Laboratory, England.
49. Navaza, J. (1994). Amore: An automated package for molecular replacement. Acta Crystallogr. A 50, 157-163.
50. McRee, D.E. (1992). A visual protein crystallographic software system for X1 1 /Xview. J. Mol. Graph. 10, 44-46.
51. Brünger, A.T. (1992). X-PLOR version 3.1. A System for X-ray Crystallography and NMR. Yale University Press, New Haven, CT.
52. Laskowski, R.A., Macarthur, M.W., Moss, D.S. & Thornton, J.M. (1993). PROCHECK: A program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26, 283-291.
53. INSIGHT II User Guide. (1997). Molecular Simulations Inc., San Diego, CA.